Literature DB >> 8561522

Visceral leishmaniasis in Ethiopia. I. Cross-sectional leishmanin skin test in an endemic locality.

A Ali1, R W Ashford.   

Abstract

A cross-sectional leishmanin skin test was carried out on a sample population of 730 individuals. The overall prevalence of leishmanin positivity was 36.4%; 50.9% of males and 23.2% of females showed positive skin test reaction. The skin-test profile in the study area is typical of an endemic focus of visceral leishmaniasis. The increase in leishmanin positivity with age parallels the age-specific disease profile and indicates an outdoor exposure to infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8561522     DOI: 10.1080/00034983.1993.11812749

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  12 in total

1.  Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil.

Authors:  Fernando Tobias Silveira; Ralph Lainson; Adelson Alcimar Almeida De Souza; Marliane Batista Campos; Liliane Almeida Carneiro; Luciana Vieira Rego Lima; Patrícia Karla Santos Ramos; Cláudia Maria de Castro Gomes; Marcia Dalastra Laurenti; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2009-11-28       Impact factor: 2.289

2.  Endemic transmission of visceral leishmaniasis in Bhutan.

Authors:  Thinley Yangzom; Israel Cruz; Caryn Bern; Daniel Argaw; Margriet den Boer; Iván Dario Vélez; Sujit K Bhattacharya; Ricardo Molina; Jorge Alvar
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

3.  Factors associated with Leishmania asymptomatic infection: results from a cross-sectional survey in highland northern Ethiopia.

Authors:  Estefanía Custodio; Endalamaw Gadisa; Luis Sordo; Israel Cruz; Javier Moreno; Javier Nieto; Carmen Chicharro; Abraham Aseffa; Zelalem Abraham; Tsegaye Hailu; Carmen Cañavate
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

4.  Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.

Authors:  Bart Ostyn; Kamlesh Gidwani; Basudha Khanal; Albert Picado; François Chappuis; Shri Prakash Singh; Suman Rijal; Shyam Sundar; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

Review 5.  Eco-epidemiology of visceral leishmaniasis in Ethiopia.

Authors:  Endalamaw Gadisa; Teshome Tsegaw; Adugna Abera; Dia-Eldin Elnaiem; Margriet den Boer; Abraham Aseffa; Alvar Jorge
Journal:  Parasit Vectors       Date:  2015-07-19       Impact factor: 3.876

6.  Prevalence and determinants of Leishmania major infection in emerging and old foci in Tunisia.

Authors:  Jihene Bettaieb; Amine Toumi; Sadok Chlif; Bilel Chelghaf; Aicha Boukthir; Adel Gharbi; Afif Ben Salah
Journal:  Parasit Vectors       Date:  2014-08-20       Impact factor: 3.876

Review 7.  Visceral leishmaniasis in Ethiopia: an evolving disease.

Authors:  Samson Leta; Thi Ha Thanh Dao; Frehiwot Mesele; Gezahegn Alemayehu
Journal:  PLoS Negl Trop Dis       Date:  2014-09-04

8.  Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India.

Authors:  Pabitra Saha; Swagata Ganguly; Moytrey Chatterjee; Soumendu Bikash Das; Pratip K Kundu; Subhasish K Guha; Tamal K Ghosh; Dilip K Bera; Nandita Basu; Ardhendu K Maji
Journal:  PLoS Negl Trop Dis       Date:  2017-02-10

9.  Visceral Leishmaniasis in Benishangul-Gumuz Regional State, Western Ethiopia: Reemerging or Emerging?

Authors:  Adugna Abera; Geremew Tasew; Teshome Tsegaw; Asfaw Kejella; Abate Mulugeta; Dagimlidet Worku; Abraham Aseffa; Endalamaw Gadisa
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

Review 10.  A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?

Authors:  Johan van Griensven; Ermias Diro; Rogelio Lopez-Velez; Koert Ritmeijer; Marleen Boelaert; Ed E Zijlstra; Asrat Hailu; Lutgarde Lynen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.